FDA Approved: BOSENTAN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bosentan submitted by Sun Pharmaceutical Industries, Inc. This approval expands the drug's labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis-associated Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)